Mediwound Stock Forward View - Simple Moving Average

MDWD Stock  USD 16.58  -0.64  -3.72%   
At Current evaluation date, Mediwound posts the short-cycle RSI reading of 41, reflecting mild downside bias. This positioning indicates that Mediwound has given back ground recently without triggering the kind of oversold extremes that attract aggressive dip-buying.
Momentum
Sell Extended
 
Oversold
 
Overbought
Forecasting Mediwound's future price from a sentiment perspective requires filtering noise from signal. This module uses a structured approach to news and hype analysis to project a probable near-term direction for Mediwound stock. Fundamental inputs shaping Mediwound's prediction context:
 EPS Estimate Next Quarter
-0.63
 EPS Estimate Current Year
-2.88
 EPS Estimate Next Year
-2.17
 Wall Street Target Price
31.3333
 EPS Estimate Current Quarter
-0.61
The hype context for Mediwound summarizes headline response alongside peer coverage. Sentiment indicators for Mediwound are summarized using options positioning and short interest.
Please check Payables Turnover and Days Of Inventory On Hand for complete statement details.
Mediwound Implied Volatility
    
  2.16  
Mediwound's implied volatility is one of the most watched metrics in options trading. Combined with historical volatility and the current option skew, it provides a comprehensive picture of how the market perceives risk in Mediwound shares.
The Simple Moving Average forecasted value of Mediwound on the next trading day is expected to be 16.58 with a mean absolute deviation of 0.36 and the sum of the absolute errors of 21.41.
Mediwound after-hype prediction price
    
  $ 16.64  
This sentiment summary adds context across forecasting, technical, analyst, and earnings perspectives for the stock.
Historical Fundamental Analysis of Mediwound provides a cross-check on projections for Mediwound. The view supplies historical context for the projection discussion.
Our How to Invest in Mediwound guide offers a complete walkthrough for buying and trading Mediwound Stock.

Rule 16 Summary for current Mediwound contract - Performance Context

Rule 16 converts implied volatility into an estimated daily move of about 0.14% for 2026-03-20 options. This context is informational: with Mediwound near $ 16.58, the daily move estimate is $ 0.0224 .

Open Interest Metrics for Mediwound 2026-03-20 Contracts

Open interest counts active Mediwound option contracts and frames participation alongside price behavior.

Mediwound Additional Predictive Modules

Most predictive techniques to examine Mediwound price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mediwound using various technical indicators. When you analyze Mediwound charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for Mediwound is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Simple Moving Average Price Forecast For the 14th of March 2026

Given 90 days horizon, the Simple Moving Average forecasted value of Mediwound on the next trading day is expected to be 16.58 with a mean absolute deviation of 0.36 , mean absolute percentage error of 0.23 , and the sum of the absolute errors of 21.41 .
Please note that although there have been many attempts to predict Mediwound Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Mediwound's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Stock Forecast Pattern

Backtest Mediwound  Mediwound Price Prediction  Research Analysis  

Forecasted Value

This next-day forecast for Mediwound uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Market Value
16.58
16.58
Expected Value
19.01
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Mediwound stock data series using in forecasting. Note that when a statistical model is used to represent Mediwound stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.802
BiasArithmetic mean of the errors 0.0618
MADMean absolute deviation0.3569
MAPEMean absolute percentage error0.0203
SAESum of the absolute errors21.415
The simple moving average model is conceptually a linear regression of the current value of Mediwound price series against current and previous (unobserved) value of Mediwound. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future
The mean reversion tendency in Mediwound's price is a well-documented phenomenon that disciplined investors can exploit by identifying when price has diverged substantially from fundamental and historical anchors.
Hype
Prediction
LowEstimatedHigh
14.2316.6419.05
Details
Intrinsic
Valuation
LowRealHigh
14.9220.4322.84
Details
Bollinger
Band Projection (param)
LowMiddleHigh
16.7817.4318.08
Details
6 Analysts
Consensus
LowTargetHigh
28.5131.3334.78
Details
Comparing Mediwound against its competitive peer group transforms raw financial data into actionable insight. Mediwound's standing on returns, margins, and growth relative to competitors is the ultimate test of its investment merit.

After-Hype Price Density Analysis

The probability distribution chart for Mediwound displays the range and likelihood of predicted price outcomes based on Mediwound's historical volatility and news impact patterns. Use the full distribution - not just the central estimate - to understand the true risk and reward.
   Next price density   
       Expected price to next headline  

Estimiated After-Hype Price Volatility

The after-hype price analysis for Mediwound uses Mediwound's historical news coverage to estimate statistically significant upside and downside price boundaries for the session following a major headline.
Current Value
16.58
16.64
After-hype Price
19.05
Upside
The after-hype framework applied to Mediwound assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.

Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Mediwound is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mediwound backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mediwound, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.20 
2.43
  0.06 
  0.02 
8 Events
7 Events
In 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
16.58
16.64
0.36 
837.93  
Notes

Hype Timeline

Mediwound is now traded for 16.58. The company has historical hype elasticity of 0.06, and average elasticity to hype of competition of -0.02. Mediwound is anticipated to increase in value after the next headline, with the price projected to jump to 16.64 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.36%, whereas the daily expected return is now at -0.2%. The volatility of related hype on Mediwound is about 3037.5%, with the expected price after the next announcement by competition of 16.56. The company reported previous year's revenue of 16.96 M. Net Loss for the year was -23.88 M with profit before overhead, payroll, taxes, and interest of 3.25 M. Given the investment horizon of 90 days the next anticipated press release will be in 8 days.
Historical Fundamental Analysis of Mediwound provides a cross-check on projections for Mediwound. The view supplies historical context for the projection discussion.
Our How to Invest in Mediwound guide offers a complete walkthrough for buying and trading Mediwound Stock.

Related Hype Analysis

Analyzing Mediwound's direct competitors. news reactions provides a leading indicator for how Mediwound may respond to comparable market events. The peer hype analysis table captures key risk and sentiment metrics across Mediwound's competitive set, helping investors anticipate.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
EPRXEupraxia Pharmaceuticals Common 0.01 8 per month 2.63 0.09 5.53 -4.46 24.61
NTHINeOnc Technologies Holdings-0.05 8 per month 5.32 0.03 8.56 -9.57 26.02
GNFTGenfit SA 0.35 7 per month 3.86 0.15 7.34 -7.71 25.18
SLSSellas Life Sciences-0.34 9 per month 5.37 0.28 14.94 -8.21 34.72
TARAProtara Therapeutics 0.01 11 per month 5.83 0.02 9.00 -6.13 38.16
IVVDInvivyd-0.04 14 per month 0.00 -0.03 8.05 -6.92 33.79
OBIOOrchestra BioMed Holdings 0.03 7 per month 3.61 0.02 7.64 -6.43 22.05
RNACCartesian Therapeutics-0.09 6 per month 4.68 0.08 8.17 -9.10 36.89
AARDAardvark Therapeutics Common-0.51 7 per month 0.00 -0.11 6.56 -10.11 68.25
IVAInventiva Sa-0.17 6 per month 2.73 0.19 7.29 -4.11 20.30

Other Forecasting Options for Mediwound

For any investor considering Mediwound, Mediwound's price movement is the central factor in determining investment viability. The noise present in Mediwound Stock price charts can distort investment decisions if not properly addressed.

Mediwound Related Equities

The following equities are related to Mediwound within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Mediwound against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
 Risk & Return  Correlation

Mediwound Market Strength Events

Market strength indicators for Mediwound stock help investors evaluate the security's behavior relative to ongoing market conditions. These tools support better market timing and help identify entry and exit signals for Mediwound.

Mediwound Risk Indicators

The analysis of Mediwound's basic risk indicators is a key input for accurate price forecasting and sound investment decisions. Understanding the risk in Mediwound's investment allows investors to make informed choices about accepting or mitigating that exposure.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Mediwound

Coverage intensity for Mediwound matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

Mediwound Short Properties

Short sentiment tied to Mediwound matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding11.4 M
Cash And Short Term Investments53.1 M

More Resources for Mediwound Stock Analysis

A structured review of Mediwound often starts with core financial statements and trend context. Ratios and trend metrics help frame Mediwound's operating context. Selected reports below provide context for Mediwound Stock:
Historical Fundamental Analysis of Mediwound provides a cross-check on projections for Mediwound. The view supplies historical context for the projection discussion.
Our How to Invest in Mediwound guide offers a complete walkthrough for buying and trading Mediwound Stock.
Analysis related to Mediwound should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
 Earnings Share
-1.84
 Revenue Per Share
1.491
 Quarterly Revenue Growth
-0.68
 Return On Assets
-0.20
 Return On Equity
-0.64
Market capitalization and book value offer complementary views of Mediwound — the first driven by investor sentiment, the second by accounting standards. Mediwound's market capitalization is 221.02 M. With a P/B ratio of 4.41, the market values Mediwound well above its book equity. Enterprise value stands at 170.2 M. Value and price for Mediwound are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Value and price for Mediwound are related but not identical, and they can diverge across cycles. For Mediwound, key inputs include a P/E ratio of 16.58, a P/B ratio of 4.41, a profit margin of -140.8%, and ROE of -63.86%. Market price reflects the current exchange level formed by active bids and offers.